94 related articles for article (PubMed ID: 8820033)
1. The effect of cimetidine on serum acidic markers and Helicobacter pylori in gastric ulcer subjects.
Lee CT; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):28-33. PubMed ID: 8820033
[TBL] [Abstract][Full Text] [Related]
2. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
[TBL] [Abstract][Full Text] [Related]
3. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
4. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
[TBL] [Abstract][Full Text] [Related]
5. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
[TBL] [Abstract][Full Text] [Related]
7. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
[TBL] [Abstract][Full Text] [Related]
8. Protein microarray analysis for detection of serum anti-Helicobacter pylori antibodies after eradication therapy: a clinical follow-up.
Cui M; Wei H; Mu F; Yi G; Fu Y; Yue L
Hepatogastroenterology; 2015; 62(138):503-6. PubMed ID: 25916090
[TBL] [Abstract][Full Text] [Related]
9. Gastric secretion and ulcer healing in mouse stomach infected with cytotoxin expressing strain of Helicobacter pylori.
Brzozowski T; Konturek PC; Konturek SJ; Karczewska E; Pajdo R; Stachura J; Ghiara P; Hahn EG
J Physiol Pharmacol; 1998 Sep; 49(3):387-403. PubMed ID: 9789792
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection and gastric secretion in duodenal and gastric ulcer patients--the effect of eradication after one year.
Laszewicz W; Zaremba-Woroniecka A; Gabryelewicz A
J Physiol Pharmacol; 1997 Sep; 48(3):353-64. PubMed ID: 9376618
[TBL] [Abstract][Full Text] [Related]
11. Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers.
Tatsuta M; Iishi H; Yokota Y
Am J Gastroenterol; 1995 Mar; 90(3):406-10. PubMed ID: 7872279
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen I and gastrin in peptic ulcer patients using nonsteroidal anti-inflammatory drugs.
Kemppainen H; Räihä I; Sourander L
Hepatogastroenterology; 1997; 44(16):1143-6. PubMed ID: 9261614
[TBL] [Abstract][Full Text] [Related]
13. High IgE serum levels and "peptic" ulcers: clinical and functional approach.
De Lazzari F; Mancin O; Plebani M; Venturi C; Battaglia G; Vianello F; Galliani EA; Di Mario F; Naccarato R
Ital J Gastroenterol; 1994; 26(1):7-11. PubMed ID: 7912969
[TBL] [Abstract][Full Text] [Related]
14. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
15. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
16. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
Mahachai V; Walker K; Pinchbeck B; Thomson AB
Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
[TBL] [Abstract][Full Text] [Related]
18. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
[TBL] [Abstract][Full Text] [Related]
19. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
Chen TS; Tsay SH; Chang FY; Lee SD
Am J Gastroenterol; 1994 Sep; 89(9):1511-4. PubMed ID: 8079929
[TBL] [Abstract][Full Text] [Related]
20. The impact of Helicobacter pylori eradication on peptic ulcer healing.
Treiber G; Lambert JR
Am J Gastroenterol; 1998 Jul; 93(7):1080-4. PubMed ID: 9672334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
